Showing results (131-140 of 470) with videos related to

Sort By:
Pageof 47
The Lancet. Rheumatology|August 25, 2020
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort studyGiacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
The Lancet. Rheumatology|May 25, 2023
Correction to Lancet Rheumatol 2022; 4: e188-97
The Lancet. Rheumatology|August 15, 2022
Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort studyDavid Simon, Koray Tascilar, Filippo Fagni, et al.
The Lancet. Rheumatology|November 7, 2022
Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility studyJennifer A E Williams, Mae Chester-Jones, Catherine Minns Lowe, et al.
The Lancet. Rheumatology|September 13, 2021
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label studyMatthias B Moor, Franziska Suter-Riniker, Michael P Horn, et al.
The Lancet. Rheumatology|February 27, 2023
Correction to Lancet Rheumatol 2022; 4: e163-66
The Lancet. Rheumatology|June 6, 2020
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort studyGiulio Cavalli, Giacomo De Luca, Corrado Campochiaro, et al.
The Lancet. Rheumatology|August 16, 2021
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysisEvdoxia Kyriazopoulou, Thomas Huet, Giulio Cavalli, et al.
The Lancet. Rheumatology|February 9, 2023
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trialMuhammad Shipa, Liliana R Santos, Dao X Nguyen, et al.
The Lancet. Rheumatology|November 22, 2025
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countriesEleana Bolla, Anne Grete Semb, Michelle Petri, et al.
Pageof 47